This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogen
This ACVR2A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 2-29 amino acids from the N-terminal region of human ACVR2A.
ACVR2 antikoerper, ACVR2A antikoerper, XSTK9 antikoerper, actrii antikoerper, acvr2 antikoerper, ACTRII antikoerper, Acvr2 antikoerper, rActR-II antikoerper, actr2a antikoerper, acvr2a antikoerper, wu:fa02e10 antikoerper, ActrIIa antikoerper, TactrII antikoerper, activin A receptor type 2A antikoerper, activin A receptor type 2A L homeolog antikoerper, activin A receptor type 2Aa antikoerper, activin receptor IIA antikoerper, ACVR2A antikoerper, acvr2a antikoerper, Acvr2a antikoerper, acvr2a.L antikoerper, acvr2aa antikoerper
Hintergrund
ACVR2A is an activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling, and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases.